injectable device testing

Device design: TNF inhibitor

With the increasing use of biologics across indications demand for new devices that meet varied patient needs is growing. Through semi-ethnographic interviews with patients and nurses we were able to understand current device usage and evaluate behaviour when using prototype designs;… Read More

pills different colours

Segmentation: biosimilars in oncology & immunology

Understanding physicians perceptions around the use of biosimilars and the drivers for use, RA Partners interviewed different physician specialities to understand if prescribing choice is driven by reasons beyond financial considerations and what the expectations of efficacy are for this new and… Read More